Aadi Bioscience Inc (AADI)

3.60 -0.13 (-3.49%) USD  |  NASDAQ  |  Jan 08, 16:00
3.595 0.00 (0.00%) After-Hours: 20:00
More

Aadi Bioscience SG&A Expense (Quarterly): 7.186M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AADI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Immuneering Corp 4.014M
Humacyte Inc 7.307M
NovaBay Pharmaceuticals Inc 2.65M
Palatin Technologies Inc 2.021M
iBio Inc 2.801M